You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

Investigational Drug Information for Proxalutamide

✉ Email this page to a colleague

« Back to Dashboard

What is the drug development status for Proxalutamide?

Proxalutamide is an investigational drug.

There have been 12 clinical trials for Proxalutamide. The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2021.

The most common disease conditions in clinical trials are COVID-19, Severe Acute Respiratory Syndrome, and Coronavirus Infections. The leading clinical trial sponsors are Suzhou Kintor Pharmaceutical Inc,, Applied Biology, Inc., and Tianjin Medical University Cancer Institute and Hospital.

There is one US patent protecting this investigational drug and four international patents.

Recent Clinical Trials for Proxalutamide
A Study to Evaluate the Efficacy and Safety of Proxalutamide (GT0918) in Hospitalized COVID-19 SubjectsIQVIA BiotechPhase 3
A Study to Evaluate the Efficacy and Safety of Proxalutamide (GT0918) in Hospitalized COVID-19 SubjectsSuzhou Kintor Pharmaceutical Inc,Phase 3
A Phase 3 Randomized, Double-Blind Placebo Controlled, Multi-regional Trial to Evaluate the Efficacy and Safety of GT0918 for the Treatment of Mild to Moderate COVID-19 Male PatientsSyneos HealthPhase 3

See all Proxalutamide clinical trials

Clinical Trial Summary for Proxalutamide

Top disease conditions for Proxalutamide
Top clinical trial sponsors for Proxalutamide

See all Proxalutamide clinical trials

International Patents for Proxalutamide

Drugname Country Document Number Estimated Expiration Related US Patent
Proxalutamide Australia AU2017321322 2036-08-29 ⤷  Sign Up
Proxalutamide Canada CA3034257 2036-08-29 ⤷  Sign Up
Proxalutamide European Patent Office EP3503898 2036-08-29 ⤷  Sign Up
Proxalutamide World Intellectual Property Organization (WIPO) WO2018044817 2036-08-29 ⤷  Sign Up
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.